Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Y Nakatsuji x
  • Refine by access: All content x
Clear All Modify Search
T Takeda
Search for other papers by T Takeda in
Google Scholar
PubMed
Close
,
H Kurachi
Search for other papers by H Kurachi in
Google Scholar
PubMed
Close
,
T Yamamoto
Search for other papers by T Yamamoto in
Google Scholar
PubMed
Close
,
Y Nishio
Search for other papers by Y Nishio in
Google Scholar
PubMed
Close
,
Y Nakatsuji
Search for other papers by Y Nakatsuji in
Google Scholar
PubMed
Close
,
K Morishige
Search for other papers by K Morishige in
Google Scholar
PubMed
Close
,
A Miyake
Search for other papers by A Miyake in
Google Scholar
PubMed
Close
, and
Y Murata
Search for other papers by Y Murata in
Google Scholar
PubMed
Close

Cytokines and steroid hormones use different sets of signal transduction pathways, which seem to be unrelated. Interleukin-6 (IL-6) uses JAK tyrosine kinase and STAT (signal transducer and activator of transcription) transcription factor. Glucocorticoid binds glucocorticoid receptor (GR), which is a member of the steroid receptor superfamily. We have studied the crosstalk between the IL-6-JAK-STAT and glucocorticoid-nuclear receptor pathways. IL-6 and glucocorticoid synergistically activated the IL-6 response element on the rat alpha2-macroglobulin promoter (APRE)-driven luciferase gene. The exogenous expression of GR enhanced the synergism. The exogenous expression of dominant negative STAT3 completely abolished the IL-6 plus glucocorticoid-induced activation of the APRE-luciferase gene. Tyrosine phosphorylation of STAT3 stimulated by IL-6 alone was not different from that by IL-6 plus glucocorticoid. The protein level of STAT3 was also not increased by glucocorticoid stimulation. The time course of STAT3 tyrosine phosphorylation by IL-6 plus glucocorticoid was not different from that by IL-6 alone. The synergism was studied on the two other IL-6 response elements, the junB promoter (JRE-IL-6) and the interferon regulatory factor-1 (IRF-1) promoter (IRF-GAS) which could be activated by STAT3. The synergistic activation by glucocorticoid on the IL-6-activated JRE-IL-6 and the IRF-GAS-driven luciferase gene was not detected. Glucocorticoid did not change the mobility of IL-6-induced APRE-binding proteins in a gel shift assay. These results suggest that the synergism was through the GR and STAT3, and the coactivation pathway which was specific for APRE was the target of glucocorticoid.

Free access